Contact this trialFirst, we need to learn more about you.
Activator
Mitapivat for Pyruvate Kinase Deficiency
Recruiting1 awardPhase 3
Aurora, Colorado
This trial will evaluate the efficacy and safety of a drug called mitapivat in children with a condition called pyruvate kinase deficiency. Children will be given either the drug or a placebo, and researchers will track how well they do.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.